Affilogic is a private biotech company specialized in discovering and developing Nanofitins^®-based therapeutics, through in house programs or collaborations with worldwide industry leaders in the pharmaceutical sector.

Recent news :

Mar 2026 – Mathieu Cinier is presenting at Nucleic Acid Therapeutics and Targeted Delivery in Banff, Canada : Come and meet Mathieu at the event, showcasing how we use Nanofitins^® for targeted delivery of oligonucleotide-based therapeutics, with examples in the brain and other organs.

Fev 2026 – Affilogic is presenting a Poster at World ADC London 2026 : meet us during the poster session to see the poster and learn on the latest data generated on our ODC program in which we use Nanofitins^® for targeted delivery of cytotoxic payloads to solid tumors.